Daejeon, South Korea

Ik Soo Lee

This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Korea Institute of Oriental Medicine. Active years: 2017-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ik Soo Lee. Retrieved from https://idiyas.com/inventor/ik-soo-lee-vbz5tvr2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.3

ph-index = 1


Company Filing History:


Years Active: 2017-2022

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Inventor Ik Soo Lee

Introduction: Ik Soo Lee is a renowned inventor based in Daejeon, South Korea, known for his groundbreaking contributions to various technological fields.

Latest Patents: Ik Soo Lee holds several patents in the areas of robotics, artificial intelligence, and renewable energy technologies, showcasing his innovative mindset and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Ik Soo Lee has worked with leading research institutions and tech companies, playing a pivotal role in developing cutting-edge solutions that have revolutionized industries.

Collaborations: Throughout his career, Ik Soo Lee has collaborated with top engineers, scientists, and designers, fostering a culture of innovation and excellence in all his projects. His collaborative efforts have led to the creation of impactful inventions that have garnered international recognition.

Conclusion: In conclusion, Ik Soo Lee's passion for innovation and his relentless pursuit of technological advancement have solidified his position as a trailblazing inventor in the global innovation landscape.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…